Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model

被引:19
作者
Cougnard, A. [1 ]
Verdoux, H. [1 ]
Grolleau, A. [1 ]
Moride, Y. [2 ]
Begaud, B. [1 ]
Tournier, M. [1 ]
机构
[1] Univ Victor Segalen Bordeaux 2, INSERM, U657, IFR Publ Hlth, Bordeaux, France
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
关键词
Antidepressant; decision analysis; depression; suicide; SEROTONIN REUPTAKE INHIBITORS; PSYCHIATRIC-DISORDER; MORTALITY; PREVALENCE; CHILDREN; THERAPY; TRIALS; ADULTS; PRIMER;
D O I
10.1017/S003329170800473X
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. The impact of antidepressant drug treatment (ADT) on the risk of suicide is uncertain. The aim of this study was to determine in a real-life setting whether ADT is associated with an increased or a reduced risk of suicide compared to absence of ADT (no-ADT) in patients with depression. Method. A decision analysis method was used to estimate the number of suicides prevented or induced by ADT in children and adolescents (10-19 years old), adults (20-64 years old) and the elderly (>= 65 years) diagnosed with major depression. The impact of gender and parasuicide history on the findings was explored within each age group. Sensitivity analyses were used to assess the robustness of the models. Results. Prescribing ADT to all patients diagnosed with depression would prevent more than one out of three suicide deaths compared to the no-ADT strategy, irrespective of age, gender or parasuicide history. Sensitivity analyses showed that persistence in taking ADT would be the main characteristic influencing the effectiveness of ADT on suicide risk. Conclusions. Public health decisions that contribute directly or indirectly to reducing the number of patients with depression who are effectively administered ADT may paradoxically induce a rise in the number of suicides.
引用
收藏
页码:1307 / 1315
页数:9
相关论文
共 41 条
[1]  
ABENHAIM L, 2003, ANAL AVAILABLE KNOWL
[2]   Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines [J].
Anderson, IM ;
Nutt, DJ ;
Deakin, JFW .
JOURNAL OF PSYCHOPHARMACOLOGY, 2000, 14 (01) :3-20
[3]  
Angst Jules, 2005, Arch Suicide Res, V9, P279, DOI 10.1080/13811110590929488
[4]  
[Anonymous], 2005, WEB BAS INJ STAT QUE
[5]  
[Anonymous], 2002, report
[6]  
AVERY D, 1976, ARCH GEN PSYCHIAT, V33, P1029
[7]   Ecological studies of antidepressant treatment and suicidal risks [J].
Baldessarini, Ross J. ;
Tondo, Leonardo ;
Strombom, Indiana M. ;
Dominguez, Svetlana ;
Fawcett, Jan ;
Licinio, Julio ;
Oquendo, Maria A. ;
Tollefson, Gary D. ;
Valuck, Robert J. ;
Tohen, Mauricio .
HARVARD REVIEW OF PSYCHIATRY, 2007, 15 (04) :133-145
[8]   Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) [J].
Bijl, RV ;
Ravelli, A ;
van Zessen, G .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1998, 33 (12) :587-595
[9]   Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other axis I disorders [J].
Chen, YW ;
Dilsaver, SC .
BIOLOGICAL PSYCHIATRY, 1996, 39 (10) :896-899
[10]  
Collet J-P., 2000, PHARMACOEPIDEMIOLOGY, V3rd, P765